Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Julphar
Cerilliant
US Army
Farmers Insurance
Accenture
Deloitte
Queensland Health
UBS
US Department of Justice

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,192,741

« Back to Dashboard

Summary for Patent: 5,192,741
Title: Sustained and controlled release of water insoluble polypeptides
Abstract:There is disclosed a pharaceutical composition for sustained and controlled release of drug over an extended period of time comprising a polylactide, a copolymer of lactic and glycolic acid, a mixture of such polymers and a water-insoluble peptide which, when placed in an aqueous physiologically-type environment releases the peptide in continuous manner for a period of at least one week, and with an initial release for the first twenty-four hours of not more than 30% of the total amount released. There is thus provided the control of the release pattern and in general a decrease of the initial burst effect.
Inventor(s): Orsolini; Piero (Martigny, CH), Mauvernay; Rolland-Yves (Lausanne, CH), Deghenghi; Romano (Lausanne, CH)
Assignee: Debiopharm S.A. (Lausanne, CH)
Application Number:07/247,060
Patent Claim Types:
see list of patent claims
Composition; Process; Dosage form; Delivery; Formulation;

Drugs Protected by US Patent 5,192,741

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,192,741

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8722134Sep 21, 1987

International Patents Family Members for US Patent 5,192,741

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 397035 ➤ Sign Up
Austria A223488 ➤ Sign Up
Australia 2232688 ➤ Sign Up
Australia 611944 ➤ Sign Up
Belgium 1001685 ➤ Sign Up
Canada 1326438 ➤ Sign Up
Switzerland 675968 ➤ Sign Up
Germany 122004000023 ➤ Sign Up
Germany 3822459 ➤ Sign Up
Denmark 175311 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Citi
Express Scripts
Boehringer Ingelheim
US Army
Farmers Insurance
Harvard Business School
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot